Company · CIK 0001819411
Gain Therapeutics, Inc.
GANXSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$1.64+$0.02 (+1.55%)
GANX · Last trade
- Prev close
- $1.62
- Range (29d)
- $1.62 – $1.95
On the record
Recent filings
- 8-KGANXCurrent report0001104659-26-112624 · 203.2 KBSEC(opens sec.gov)
- 8-KGANXCurrent report0001104659-26-111391 · 193.3 KBSEC(opens sec.gov)
- 10-QGANXQuarterly update0001104659-26-094048 · 8.3 MBSEC(opens sec.gov)
- 8-KGANXCurrent report0001104659-26-094041 · 362.9 KBSEC(opens sec.gov)
- 8-KGANXCurrent report0001104659-26-084086 · 193.1 KBSEC(opens sec.gov)
- 8-KGANXCurrent report0001104659-26-078848 · 194.9 KBSEC(opens sec.gov)
- 8-KGANXCurrent report0001104659-26-077820 · 201.2 KBSEC(opens sec.gov)
- 8-KGANXCurrent report0001104659-26-066062 · 586.0 KBSEC(opens sec.gov)
- 10-QGANXQuarterly update0001104659-26-058649 · 7.5 MBSEC(opens sec.gov)
- 8-KGANXCurrent report0001104659-26-058636 · 321.8 KBSEC(opens sec.gov)
Insiders
- Alder MatthiasDirector, Chief Executive Officer
- Ballantyne Charles EvanChief Financial Officer
- Bellotto ManoloPresident and General Manager
- Calabrese SalvatoreChief Financial Officer
- Fuggetta GianlucaSee Remark
- GOLDSTEIN DOV A MDDirector
- HASLER HANS PETERDirector
- Islam KhalidDirector
- Mack GeneDirector, CEO, President
- Melincoff Gwen ADirector
Tickers
Addresses
business
4800 HAMPDEN LANE SUITE 200
BETHESDA, MD, 20814
mailing
4800 HAMPDEN LANE SUITE 200
BETHESDA, MD, 20814
Same industry